Announcements Trials
Browse Landscape

Phase

Phase 2 36Phase 1 28Phase 1/2 18Phase NA 7Phase 3 5Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 43Unknown 15Active not recruiting 12Recruiting 11Terminated 5Not yet recruiting 4Withdrawn 3

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5

Conditions

Carcinoma, Non-Small-Cell Lung 92Breast Neoplasms 85Neoplasms 79Prostatic Neoplasms 50Lung Neoplasms 43Neoplasm Metastasis 40Colorectal Neoplasms 37Leukemia, Myeloid, Acute 32Pain 27Head and Neck Neoplasms 25Colonic Neoplasms 25Multiple Myeloma 24Ovarian Neoplasms 23Lymphoma 23Carcinoma, Hepatocellular 23Pancreatic Neoplasms 22Lymphoma, Follicular 21Melanoma 20Leukemia 20Rectal Neoplasms 19Lymphoma, Non-Hodgkin 19Urinary Bladder Neoplasms 17Recurrence 17Stomach Neoplasms 15Lymphoma, Large B-Cell, Diffuse 15Leukemia, Lymphocytic, Chronic, B-Cell 15Squamous Cell Carcinoma of Head and Neck 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leiomyoma 13Brain Neoplasms 13

Interventions

trebananib 2Paclitaxel 2talazoparib 1pembrolizumab 1liposomal doxorubicin 1Topotecan 1Taxes 1Gemcitabine 1Drug Therapy 1Doxorubicin 1Carboplatin 11-dodecylpyridoxal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Fallopian Tube Neoplasms × Clear all
NCT05092360 2025-08-28

ARTISTRY-7

Mural Oncology, Inc

Phase 3 Terminated
456 enrolled 19 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05329545 2023-10-26

UP-NEXT

Mersana Therapeutics

Phase 3 Terminated
20 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT03642132 2023-04-06

JAVELIN OVARIAN PARP100

Pfizer

Phase 3 Terminated
79 enrolled 18 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01281254 2017-12-02

TRINOVA-2

Amgen

Phase 3 Terminated
223 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01493505 2017-02-23

TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer

Amgen

Phase 3 Terminated
1,015 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡